Ciprofibrate increases cholesteryl ester transfer protein gene expression and the indirect reverse cholesterol transport to the liver

BACKGROUND: CETP is a plasma protein that modulates atherosclerosis risk through its HDL-cholesterol reducing action. The aim of this work was to examine the effect of the PPARα agonist, ciprofibrate, on the CETP gene expression, in the presence and absence of apolipoprotein (apo) CIII induced hyper...

Full description

Saved in:
Bibliographic Details
Main Authors: Bighetti, Eliete JB, Patrício, Patrícia R, Casquero, Andrea C, Berti, Jairo A, Oliveira, Helena CF
Format: Artigo
Language:Inglês
Published: BioMed Central 2009
Subjects:
Research
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC2784759/
https://ncbi.nlm.nih.gov/pubmed/19930639
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1476-511X-8-50
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items